If you are a doctor, the odds are that your patients think or do things you don’t agree with. Nearly half of Americans believe at least one health-related conspiracy theory, people routinely lie to ...

In May 2023, Joanna Loewenstein MD opened her concierge internal medicine practice in New York City, the first of its kind at Weill Cornell. Growing up in Long Island, Dr. Lowenstein remembers her dad ...

Recently, a long-standing patient came in for her routine office follow-up appointment for management of hypertension and arthritis. After a warm greeting, she told me there was a matter she needed to ...

Miscarriage early in pregnancy is very common—roughly one-fifth of detected pregnancies are thought to end in miscarriage, mostly in the first trimester. After a single miscarriage, patients are ...

"By embracing a DTC sales model, pharmaceutical companies and the patients that consume their drugs can essentially cut PBMs and other middlemen out of the picture," writes Pipes. Several Big Pharma ...

July 10 (Reuters) - Only one in four U.S. patients prescribed Novo Nordisk’s (NOVOb.CO), opens new tab Wegovy or Ozempic for weight loss were still taking the popular medications two years later, ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...

Some treatments and procedures become routine despite lacking strong evidence to show that they’re beneficial. Recent studies have called a few into question. By Paula Span An older patient with ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

The outcomes from real-life clinical studies regarding the optimal revascularization strategy in patients with multivessel coronary artery disease (MVD) are still poorly investigated. In this ...